Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) (NWG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)Trade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) vs State Street SPDR S&P Biotech ETF — how do they compare? NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.13 (market cap $66.98B), while State Street SPDR S&P Biotech ETF trades at $153.7 (market cap $10.11B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 6.6× State Street SPDR S&P Biotech ETF's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays a 5.5% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 1 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.

NWGXBI
Market Cap
$66.98B$10.11B
Volume
5,259,06012,903,266
Sector
FinancialsBroad Market / Factor
52-Week High
$19.42$169.55
52-Week Low
$13.89$104.99
Typical Hold Time
1 Days38 Days
Enterprise Value
$140.55B—
Dividend Yield
5.5%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.

Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.

Returns comparison

Trailing returns across standard periods

About NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.

Read more on NWG →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →